JACK Z.GOUGOUTAS JZ,.古古塔斯,HILDEGARD LOBINGER H,.洛賓格,SRIVIDYA RAMAKRISHNAN S,.羅摩克里斯納,PRASHANT P. DESHPANDE PP,.德什潘德,JEFFREY T. BIEN JT,.比恩,CHIAJEN LAI,賴佳仁,CHENCHI WANG,王貞棋,PETER RIEBEL P,.里布爾,JOHN ANTH
申请号：
HK15107967.7
公开号：
HK1207370A
申请日:
2015.08.18
申请国别(地区):
HK
年份:
2016
代理人:
摘要：
The invention relates to crystal structures and preparation methods of SGLT2 inhibitors, concretely relates to physical crystal structures of compounds represented by formula I shown in the specification, and especially relates to medicinal compositions containing the compounds I or II, preparation methods of the compounds, intermediates for preparing the structures, and methods for treating diseases, such as diabetes by using the structures. In the formula II, R<1>, R<2>, R<2a>, R<3> and R<4> are defined as in the specification.
